Symbols / TOI $3.08 -0.96% The Oncology Institute, Inc.

Healthcare • Medical Care Facilities • United States • NCM
TOI Chart
About

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Care Facilities Market Cap 304.42M
Enterprise Value 374.61M Income -50.30M Sales 502.73M
Book/sh -0.16 Cash/sh 0.34 Dividend Yield —
Payout 0.00% Employees 641 IPO —
P/E — Forward P/E -19.25 PEG —
P/S 0.61 P/B -19.37 P/C —
EV/EBITDA -12.86 EV/Sales 0.74 Quick Ratio 1.31
Current Ratio 1.59 Debt/Eq — LT Debt/Eq —
EPS (ttm) -0.54 EPS next Y -0.16 EPS Growth —
Revenue Growth 41.60% Earnings 2026-05-11 ROA -13.37%
ROE — ROIC — Gross Margin 15.20%
Oper. Margin -4.87% Profit Margin -12.06% Shs Outstand 98.84M
Shs Float 64.74M Short Float 10.96% Short Ratio 4.89
Short Interest — 52W High 4.88 52W Low 1.62
Beta 0.20 Avg Volume 1.98M Volume 1.28M
Target Price $7.00 Recom None Prev Close $3.11
Price $3.08 Change -0.96%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.00
Mean price target
2. Current target
$3.08
Latest analyst target
3. DCF / Fair value
$-2.00
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.08
Low
$5.00
High
$8.00
Mean
$7.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-13 main B. Riley Securities Buy → Buy $8
2026-03-13 reit Needham Buy → Buy $5
2026-03-09 reit Needham Buy → Buy $5
2026-03-09 reit BTIG Buy → Buy $7
2025-11-25 init Needham — → Buy $5
2025-10-21 reit BTIG Buy → Buy $7
2025-07-16 init B. Riley Securities — → Buy $6
2023-06-16 main Guggenheim — → Buy $2
2023-03-20 main Guggenheim — → Neutral $3
2022-11-11 main Guggenheim — → Buy $6
2022-08-15 init Jefferies — → Buy $10
News
RSS: Latest TOI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-27 CARTER ROBERT ROSS Chief Financial Officer — 202,914 $0.00 $0
2026-03-27 LANGSAM JEFFREY Officer — 70,270 $0.00 $0
2026-03-27 ENGLAND KRISTIN Officer — 55,743 $0.00 $0
2026-03-27 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 27,429 $2.96 $81,190
2026-03-27 VIRNICH DANIEL Chief Executive Officer — 670,608 $0.00 $0
2026-03-27 PODNOS YALE Officer — 66,446 $0.00 $0
2026-03-26 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 50,000 $3.15 $157,500
2026-03-24 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 125,000 $3.11 $388,750
2026-03-20 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 25,000 $3.35 $83,750
2026-03-17 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 398,985 $2.92 $1,225,101
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
502.73
+27.79%
393.41
+21.33%
324.24
+28.42%
252.48
Operating Revenue
502.73
+27.79%
393.41
+21.33%
324.24
+28.42%
252.48
Cost Of Revenue
426.29
+25.60%
339.42
+28.24%
264.67
+32.08%
200.39
Reconciled Cost Of Revenue
426.29
+25.60%
339.42
+28.24%
264.67
+32.08%
200.39
Gross Profit
76.44
+41.55%
54.00
-9.36%
59.57
+14.36%
52.09
Operating Expense
112.52
-1.40%
114.11
-4.68%
119.72
-3.53%
124.10
Selling General And Administration
105.57
-2.09%
107.83
-5.29%
113.85
-4.88%
119.69
Total Expenses
538.81
+18.80%
453.53
+17.99%
384.39
+18.46%
324.49
Operating Income
-36.08
+39.98%
-60.12
+0.05%
-60.15
+16.47%
-72.01
Total Operating Income As Reported
-36.08
+39.98%
-60.12
+21.94%
-77.02
+6.02%
-81.95
EBITDA
-42.52
+16.44%
-50.88
+27.78%
-70.45
-938.54%
8.40
Normalized EBITDA
-30.06
+44.53%
-54.20
+1.43%
-54.98
+18.05%
-67.09
Reconciled Depreciation
6.94
+10.45%
6.29
+7.05%
5.87
+33.14%
4.41
EBIT
-49.46
+13.48%
-57.17
+25.10%
-76.33
-2012.48%
3.99
Total Unusual Items
-12.45
-475.54%
3.32
+121.43%
-15.47
-120.49%
75.50
Total Unusual Items Excluding Goodwill
-12.45
-475.54%
3.32
+121.43%
-15.47
-120.49%
75.50
Special Income Charges
—
0.00
+100.00%
-16.06
-132.48%
49.45
Other Special Charges
—
—
—
-0.18
Impairment Of Capital Assets
—
0.00
-100.00%
16.87
+69.62%
9.94
Restructuring And Mergern Acquisition
—
0.00
+100.00%
-0.80
+98.64%
-59.22
Net Income
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Pretax Income
-60.74
+6.07%
-64.66
+22.19%
-83.10
-91223.08%
-0.09
Net Non Operating Interest Income Expense
-11.28
-50.43%
-7.50
-10.61%
-6.78
-66.02%
-4.08
Interest Expense Non Operating
11.28
+50.43%
7.50
+10.61%
6.78
+66.02%
4.08
Net Interest Income
-11.28
-50.43%
-7.50
-10.61%
-6.78
-66.02%
-4.08
Interest Expense
11.28
+50.43%
7.50
+10.61%
6.78
+66.02%
4.08
Other Income Expense
-13.38
-553.34%
2.95
+118.24%
-16.18
-121.28%
76.00
Other Non Operating Income Expenses
-0.93
-153.42%
-0.36
+48.15%
-0.70
-240.52%
0.50
Gain On Sale Of Security
-12.45
-475.54%
3.32
+460.14%
0.59
-97.73%
26.04
Tax Provision
-0.13
0.00
+100.00%
-0.04
+85.19%
-0.24
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
-99.79%
0.00
Tax Effect Of Unusual Items
-0.03
0.00
+100.00%
-0.01
-100.04%
15.85
Net Income Including Noncontrolling Interests
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Net Income From Continuing Operation Net Minority Interest
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Net Income From Continuing And Discontinued Operation
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Net Income Continuous Operations
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Normalized Income
-48.18
+29.13%
-67.98
-0.56%
-67.60
-13.64%
-59.49
Net Income Common Stockholders
-50.30
+5.09%
-53.01
+21.91%
-67.88
-99919.12%
0.07
Otherunder Preferred Stock Dividend
-10.30
+11.64%
-11.66
+23.26%
-15.19
-18184.52%
0.08
Diluted EPS
—
-0.71
+22.83%
-0.92
-360.00%
-0.20
Basic EPS
—
-0.71
+22.83%
-0.92
-4700.00%
0.02
Basic Average Shares
—
75.04
+1.76%
73.75
+1.31%
72.79
Diluted Average Shares
—
75.04
+1.76%
73.75
-8.51%
80.61
Diluted NI Availto Com Stockholders
-50.30
+5.09%
-53.01
+21.91%
-67.88
-299.75%
-16.98
Average Dilution Earnings
—
—
0.00
+100.00%
-17.05
Depreciation Amortization Depletion Income Statement
6.94
+10.45%
6.29
+7.05%
5.87
+33.14%
4.41
Depreciation And Amortization In Income Statement
6.94
+10.45%
6.29
+7.05%
5.87
+33.14%
4.41
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
164.66
-4.67%
172.72
-17.46%
209.24
Current Assets
112.75
+0.29%
112.42
-21.66%
143.49
Cash Cash Equivalents And Short Term Investments
33.56
-32.42%
49.67
-40.05%
82.86
Cash And Cash Equivalents
33.56
-32.42%
49.67
+48.32%
33.49
Cash Financial
—
—
—
Other Short Term Investments
—
0.00
-100.00%
49.37
Receivables
59.32
+21.85%
48.68
+13.45%
42.91
Accounts Receivable
59.00
+22.06%
48.34
+14.11%
42.36
Other Receivables
0.32
-6.94%
0.35
-37.21%
0.55
Accrued Interest Receivable
—
—
0.24
Inventory
16.88
+68.09%
10.04
-26.60%
13.68
Finished Goods
16.88
+68.09%
10.04
-26.60%
13.68
Prepaid Assets
—
—
4.05
Restricted Cash
—
—
—
Other Current Assets
2.99
-25.86%
4.03
-0.49%
4.05
Total Non Current Assets
51.91
-13.91%
60.30
-8.29%
65.75
Net PPE
33.06
-12.24%
37.67
-5.95%
40.05
Gross PPE
43.98
-1.47%
44.64
-3.44%
46.23
Accumulated Depreciation
-10.93
-56.71%
-6.97
-12.82%
-6.18
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
5.92
+28.65%
4.60
+22.37%
3.76
Construction In Progress
1.14
+972.64%
0.11
-94.11%
1.80
Other Properties
24.08
-12.23%
27.43
-12.79%
31.46
Leases
12.85
+2.78%
12.50
+35.68%
9.21
Goodwill And Other Intangible Assets
18.25
-17.22%
22.04
-12.31%
25.13
Goodwill
7.23
+0.00%
7.23
+0.00%
7.23
Other Intangible Assets
11.02
-25.62%
14.81
-17.28%
17.90
Investments And Advances
—
—
0.00
Other Non Current Assets
0.61
+2.89%
0.59
+4.99%
0.56
Total Liabilities Net Minority Interest
180.38
+6.65%
169.13
+11.11%
152.22
Current Liabilities
70.96
+35.90%
52.22
+50.09%
34.79
Payables And Accrued Expenses
48.37
+76.52%
27.40
+39.73%
19.61
Payables
43.17
+77.47%
24.32
+68.58%
14.43
Accounts Payable
43.17
+77.47%
24.32
+68.58%
14.43
Current Accrued Expenses
5.20
+69.02%
3.08
-40.58%
5.18
Pensionand Other Post Retirement Benefit Plans Current
7.09
+1.69%
6.97
+26.40%
5.52
Total Tax Payable
—
—
0.00
Income Tax Payable
—
—
0.00
Current Debt And Capital Lease Obligation
7.16
+5.27%
6.80
+6.84%
6.36
Current Debt
—
—
—
Current Capital Lease Obligation
7.16
+5.27%
6.80
+6.84%
6.36
Current Deferred Liabilities
4.04
-29.53%
5.73
+73.82%
3.30
Current Deferred Revenue
2.28
-2.93%
2.35
+115.69%
1.09
Other Current Liabilities
4.30
-18.93%
5.31
+47.46%
3.60
Total Non Current Liabilities Net Minority Interest
109.41
-6.41%
116.91
-0.44%
117.43
Long Term Debt And Capital Lease Obligation
96.53
-17.04%
116.35
+2.68%
113.31
Long Term Debt
77.40
-16.89%
93.13
+7.26%
86.83
Long Term Capital Lease Obligation
19.13
-17.62%
23.22
-12.32%
26.49
Non Current Deferred Liabilities
0.00
-100.00%
0.03
+0.00%
0.03
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.03
+0.00%
0.03
Other Non Current Liabilities
0.03
-77.60%
0.12
-65.75%
0.36
Stockholders Equity
-15.72
-538.01%
3.59
-93.71%
57.02
Common Stock Equity
-15.72
-538.01%
3.59
-93.71%
57.02
Capital Stock
0.01
+25.00%
0.01
+0.00%
0.01
Common Stock
0.01
+25.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
Share Issued
100.60
+29.85%
77.47
+2.10%
75.88
Ordinary Shares Number
98.86
+30.53%
75.74
+2.15%
74.15
Treasury Shares Number
1.73
+0.00%
1.73
+0.00%
1.73
Additional Paid In Capital
256.71
+19.17%
215.41
+5.50%
204.19
Retained Earnings
-271.42
-28.75%
-210.81
-44.24%
-146.15
Treasury Stock
1.02
+0.00%
1.02
+0.00%
1.02
Total Equity Gross Minority Interest
-15.72
-538.01%
3.59
-93.71%
57.02
Total Capitalization
61.68
-36.23%
96.72
-32.76%
143.85
Working Capital
41.78
-30.59%
60.20
-44.62%
108.70
Invested Capital
61.68
-36.23%
96.72
-32.76%
143.85
Total Debt
103.69
-15.81%
123.15
+2.91%
119.67
Net Debt
43.84
+0.86%
43.46
-18.52%
53.34
Capital Lease Obligations
26.29
-12.44%
30.02
-8.61%
32.85
Net Tangible Assets
-33.97
-84.08%
-18.45
-157.86%
31.89
Tangible Book Value
-33.97
-84.08%
-18.45
-157.86%
31.89
Available For Sale Securities
—
—
—
Derivative Product Liabilities
12.86
+3097.76%
0.40
-89.19%
3.72
Interest Payable
0.88
-22.71%
1.14
+1.07%
1.12
Investmentin Financial Assets
—
—
0.00
Line Of Credit
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.59
+7.35%
-26.54
+26.92%
-36.31
+41.20%
-61.76
Cash Flow From Continuing Operating Activities
-24.59
+7.35%
-26.54
+26.92%
-36.31
+41.20%
-61.76
Net Income From Continuing Operations
-60.61
+6.27%
-64.66
+22.16%
-83.07
-54750.00%
0.15
Depreciation Amortization Depletion
6.94
+10.45%
6.29
+7.05%
5.87
+33.14%
4.41
Depreciation And Amortization
6.94
+10.45%
6.29
+7.05%
5.87
+33.14%
4.41
Other Non Cash Items
8.38
+32.91%
6.30
+16.72%
5.40
+109.52%
-56.77
Stock Based Compensation
4.55
-59.19%
11.15
-37.38%
17.81
-35.66%
27.68
Asset Impairment Charge
—
0.00
-100.00%
18.89
+81.26%
10.42
Deferred Tax
-0.03
0.00
+100.00%
-0.08
+71.10%
-0.26
Deferred Income Tax
-0.03
0.00
+100.00%
-0.08
+71.10%
-0.26
Operating Gains Losses
14.85
+587.72%
-3.04
-389.55%
-0.62
+97.63%
-26.20
Gain Loss On Investment Securities
14.85
+547.86%
-3.32
-460.14%
-0.59
+97.73%
-26.04
Unrealized Gain Loss On Investment Securities
0.00
+100.00%
-0.13
+46.59%
-0.25
-165.87%
0.38
Gain Loss On Sale Of PPE
0.00
-100.00%
0.27
+1003.33%
-0.03
-242.86%
0.02
Change In Working Capital
1.32
-92.66%
18.06
+665.54%
2.36
+111.48%
-20.54
Change In Receivables
-12.58
-118.06%
-5.77
-28.28%
-4.50
+77.13%
-19.66
Changes In Account Receivables
-12.31
-105.99%
-5.97
-30.92%
-4.56
+77.50%
-20.29
Change In Inventory
-6.84
-287.85%
3.64
+182.99%
-4.38
-153.18%
-1.73
Change In Prepaid Assets
2.03
+72.87%
1.18
-62.40%
3.13
-26.95%
4.28
Change In Payables And Accrued Expense
19.19
+2.70%
18.69
+129.02%
8.16
+319.62%
-3.71
Change In Accrued Expense
-0.45
-104.73%
9.47
+182.13%
3.36
+42.91%
2.35
Change In Payable
19.64
+113.11%
9.21
+91.90%
4.80
+179.19%
-6.06
Change In Account Payable
19.64
+113.11%
9.21
+82.22%
5.06
+181.74%
-6.19
Change In Other Working Capital
-0.45
-180.86%
0.56
—
—
Change In Other Current Assets
-0.02
+39.29%
-0.03
-100.49%
5.72
+9.05%
5.25
Change In Other Current Liabilities
-0.01
+94.58%
-0.20
+96.48%
-5.77
-16.32%
-4.96
Investing Cash Flow
-3.07
-106.65%
46.21
-26.23%
62.64
+147.59%
-131.61
Cash Flow From Continuing Investing Activities
-3.07
-106.65%
46.21
-26.23%
62.64
+147.59%
-131.61
Net PPE Purchase And Sale
-3.20
+15.54%
-3.79
+17.04%
-4.57
+17.40%
-5.53
Purchase Of PPE
-3.20
+15.54%
-3.79
+17.04%
-4.57
+17.40%
-5.53
Capital Expenditure
-3.20
+15.54%
-3.79
+17.04%
-4.57
+17.40%
-5.53
Net Investment Purchase And Sale
0.00
-100.00%
50.00
-30.23%
71.66
+160.99%
-117.51
Purchase Of Investment
—
0.00
+100.00%
-9.60
+91.83%
-117.51
Sale Of Investment
0.00
-100.00%
50.00
-38.47%
81.26
0.00
Net Business Purchase And Sale
—
0.00
+100.00%
-4.46
+48.05%
-8.58
Purchase Of Business
—
0.00
+100.00%
-4.46
+48.05%
-8.58
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Net Other Investing Changes
0.13
—
—
—
Financing Cash Flow
11.56
+430.96%
-3.49
+49.00%
-6.85
-107.43%
92.21
Cash Flow From Continuing Financing Activities
11.56
+430.96%
-3.49
+49.00%
-6.85
-107.43%
92.21
Net Issuance Payments Of Debt
-20.04
-51276.92%
-0.04
+61.39%
-0.10
-100.09%
109.94
Issuance Of Debt
—
—
0.00
-100.00%
110.00
Repayment Of Debt
-20.04
-51276.92%
-0.04
+61.39%
-0.10
-74.14%
-0.06
Long Term Debt Issuance
—
—
0.00
-100.00%
110.00
Long Term Debt Payments
-20.04
-51276.92%
-0.04
+61.39%
-0.10
-74.14%
-0.06
Net Long Term Debt Issuance
-20.04
-51276.92%
-0.04
+61.39%
-0.10
-100.09%
109.94
Net Common Stock Issuance
29.20
0.00
+100.00%
-1.02
+88.68%
-9.00
Common Stock Payments
—
0.00
+100.00%
-1.02
+88.68%
-9.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-1.02
+88.68%
-9.00
Proceeds From Stock Option Exercised
3.44
+4480.00%
0.07
-40.48%
0.13
-85.31%
0.86
Net Other Financing Charges
-1.04
+70.49%
-3.53
+39.72%
-5.85
+38.99%
-9.59
Changes In Cash
-16.10
-199.52%
16.18
-16.93%
19.48
+119.25%
-101.16
Beginning Cash Position
49.67
+48.32%
33.49
+139.03%
14.01
-87.84%
115.17
End Cash Position
33.56
-32.42%
49.67
+48.32%
33.49
+139.03%
14.01
Free Cash Flow
-27.79
+8.38%
-30.33
+25.82%
-40.88
+39.24%
-67.28
Interest Paid Supplemental Data
3.91
-12.98%
4.50
-0.18%
4.51
+1911.61%
0.22
Income Tax Paid Supplemental Data
—
0.00
-100.00%
0.40
+168.67%
0.15
Amortization Of Securities
0.00
+100.00%
-0.50
+81.00%
-2.63
-157.94%
-1.02
Change In Income Tax Payable
—
0.00
+100.00%
-0.26
-307.32%
0.12
Change In Tax Payable
—
0.00
+100.00%
-0.26
-307.32%
0.12
Common Stock Issuance
29.20
0.00
—
—
Issuance Of Capital Stock
29.20
0.00
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category